Fátima Rodriguez, MD, explains how the new cardiovascular-kidney-metabolic (CKM) syndrome guideline addresses health equity, risk prediction, and the pharmacist's role in care.
Fátima Rodriguez, MD, MPH, FAHA, FACC
Advertisement
Fátima Rodriguez, MD, MPH, FAHA, FACC, is vice chair of the American Heart Association (AHA)/American College of Cardiology (ACC) cardio-kidney-metabolic (CKM) syndrome guideline writing committee and an associate professor of cardiovascular medicine at Stanford Medicine.
Articles by Fátima Rodriguez, MD, MPH, FAHA, FACC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
2
Drug Shortages Are Declining, But Persistent Supply Chain Vulnerabilities Continue to Threaten Access
3
The Peptide Surge: Counseling Guidance on GLP-1s, Compounded Therapies, and What Patients Want to Know
4
FDA Adds a New Sunscreen to the OTC Repertoire
5